Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Emmanuel Massy"'
Autor:
Pierre Sesques, Lionel Karlin, Emmanuel Massy, Alizée Maarek, Guillaume Aussedat, Anne Lazareth, Camille Golfier, Fadhela Bouafia-Sauvy, Helene Lequeu, Dana Ghergus, Violaine Safar, Emmanuelle Ferrant, Emmanuel Bachy, Hervé Ghesquières, Cyrille B. Confavreux, Delphine Demangel, Emeline Perrial, Charles Dumontet
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundIn spite of spectacular advances in the treatment of multiple myeloma, a majority of patients will die from this disease or related complications. While a great amount of focus has been dedicated to the development of novel therapies, littl
Externí odkaz:
https://doaj.org/article/4a125c6c53de4fb0b5064a8ef7afa57d
Autor:
Alexiane Pradelle, Sabine Mainbourg, Steeve Provencher, Emmanuel Massy, Guillaume Grenet, Jean-Christophe Lega
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 179, Iss , Pp 117353- (2024)
Externí odkaz:
https://doaj.org/article/4fb0ae46cc43446cb43b71fe16be51d8
Autor:
Alexiane PRADELLE, Sabine MAINBOURG, Steeve PROVENCHER, Emmanuel MASSY, Guillaume GRENET, Jean-Christophe LEGA
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 171, Iss , Pp 116055- (2024)
Background: During the first wave of COVID-19, hydroxychloroquine (HCQ) was used off-label despite the absence of evidence documenting its clinical benefits. Since then, a meta-analysis of randomised trials showed that HCQ use was associated with an
Externí odkaz:
https://doaj.org/article/add263c9c8a84cae961bd1487eab1c63
Autor:
Nathalie Balandraud, Gaetan Texier, Emmanuel Massy, Olivier Muis-Pistor, Marielle Martin, Isabelle Auger, Marie-Caroline Guzian, Sandrine Guis, Thao Pham, Jean Roudier
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171623 (2017)
BACKGROUND:Epstein-Barr Virus (EBV) is a widely disseminated lymphotropic herpes virus implicated in benign and malignant disorders. In transplant patients, immunosuppressive drugs (cyclosporine) diminish control of EBV replication, potentially leadi
Externí odkaz:
https://doaj.org/article/c9ad29e253284a08bfb3c718cd8d4e97
Autor:
Maxime Auroux, Benjamin Laurent, Baptiste Coste, Emmanuel Massy, Alexandre Mercier, Isabelle Durieu, Cyrille B Confavreux, Jean-Christophe Lega, Sabine Mainbourg, Fabienne Coury
Publikováno v:
Revue du Rhumatisme. 89:435-446
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f4824186b337eb975bf5388ef78a115
https://doi.org/10.1016/j.rhum.2022.07.002
https://doi.org/10.1016/j.rhum.2022.07.002
Publikováno v:
Revue du Rhumatisme.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60cff31e122ffb7a1ffb0687293729e0
https://doi.org/10.1016/j.rhum.2023.05.006
https://doi.org/10.1016/j.rhum.2023.05.006
Autor:
David Goncalves, Denis Maillet, Emmanuel Massy, Thomas Tingry, Nicole Fabien, Nicolas Girard, Marie Kostine, Muriel Piperno, Maxime Auroux, Charline Estublier, Cyrille B. Confavreux, Mona Amini-Adle
Publikováno v:
Bulletin du Cancer. 108:643-653
New anti-cancer therapeutics have been developed in the recent years and dramatically change prognosis and patient management. Either used alone or in combination, immune checkpoint inhibitors (ICI), such as anti-CTLA-4 and anti-PD1/PD-(L)1, act by r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41b2170758a9aa87ce0f6947a3ee9f04
https://doi.org/10.1016/j.bulcan.2021.01.016
https://doi.org/10.1016/j.bulcan.2021.01.016
Publikováno v:
Joint Bone Spine. 90:105530
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a5c529fa646f0112cdf547a0684450f
https://doi.org/10.1016/j.jbspin.2023.105530
https://doi.org/10.1016/j.jbspin.2023.105530
Autor:
Maxime Auroux, Benjamin Laurent, Baptiste Coste, Emmanuel Massy, Alexandre Mercier, Isabelle Durieu, Cyrille B. Confavreux, Jean-Christophe Lega, Sabine Mainbourg, Fabienne Coury
Publikováno v:
Joint bone spine. 89(5)
Vaccination is considered as a cornerstone of the management of COVID-19 pandemic. However, while vaccines provide a robust protection in immunocompetent individuals, the immunogenicity in patients with inflammatory rheumatic diseases (IRD) is not we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74a1a400896b35c3e329e9ebe6a28bfc
https://pubmed.ncbi.nlm.nih.gov/35490940
https://pubmed.ncbi.nlm.nih.gov/35490940
Autor:
Emmanuel Massy, Pascal Pedini, Eloise Pollet, Marielle Martin, Jean Roudier, Christophe Picard, Nathalie Balandraud
Publikováno v:
Human Immunology
Human Immunology, In press, 83, pp.515-520. ⟨10.1016/j.humimm.2022.04.001⟩
Human Immunology, Elsevier, In press, 83, pp.515-520. ⟨10.1016/j.humimm.2022.04.001⟩
Human Immunology, 2022, ⟨10.1016/j.humimm.2022.04.001⟩
Human Immunology, In press, 83, pp.515-520. ⟨10.1016/j.humimm.2022.04.001⟩
Human Immunology, Elsevier, In press, 83, pp.515-520. ⟨10.1016/j.humimm.2022.04.001⟩
Human Immunology, 2022, ⟨10.1016/j.humimm.2022.04.001⟩
International audience; Psoriatic arthritis (PsA) is a type of inflammatory arthritis associated with psoriasis. HLA association studies performed in northern Europe, comparing patients with control populations, have shown that the highest risk for P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::015cbed2e90f23e357de5b18e06b3171
https://pubmed.ncbi.nlm.nih.gov/35428536
https://pubmed.ncbi.nlm.nih.gov/35428536